Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans.

Nahler G, Grotenhermen F, Zuardi AW, Crippa JAS.

Cannabis Cannabinoid Res. 2017 May 1;2(1):81-86. doi: 10.1089/can.2017.0009. eCollection 2017.

2.

Conversion of Cannabidiol Following Oral Administration: Authors' Response to Grotenhermen et al. DOI: 10.1089/can.2016.0036.

Bonn-Miller MO, Banks SL, Sebree T.

Cannabis Cannabinoid Res. 2017 Jan 1;2(1):5-7. doi: 10.1089/can.2016.0038. eCollection 2017.

3.

Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102-112; DOI: 10.1089/can.2015.0004.

Grotenhermen F, Russo E, Zuardi AW.

Cannabis Cannabinoid Res. 2017 Jan 1;2(1):1-4. doi: 10.1089/can.2016.0036. eCollection 2017.

4.

Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity.

Britch SC, Wiley JL, Yu Z, Clowers BH, Craft RM.

Drug Alcohol Depend. 2017 Jun 1;175:187-197. doi: 10.1016/j.drugalcdep.2017.01.046. Epub 2017 Apr 15.

PMID:
28445853
5.

Medical cannabis - the Canadian perspective.

Ko GD, Bober SL, Mindra S, Moreau JM.

J Pain Res. 2016 Sep 30;9:735-744. eCollection 2016. Review.

6.

Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues.

Russo EB.

Front Pharmacol. 2016 Sep 14;7:309. doi: 10.3389/fphar.2016.00309. eCollection 2016. Review.

7.

Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review.

Angarita GA, Emadi N, Hodges S, Morgan PT.

Addict Sci Clin Pract. 2016 Apr 26;11(1):9. doi: 10.1186/s13722-016-0056-7. Review.

8.

Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study.

Maple KE, McDaniel KA, Shollenbarger SG, Lisdahl KM.

Am J Drug Alcohol Abuse. 2016 Jul;42(4):431-40. doi: 10.3109/00952990.2016.1141913. Epub 2016 Apr 13.

9.

Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.

Trigo JM, Lagzdins D, Rehm J, Selby P, Gamaleddin I, Fischer B, Barnes AJ, Huestis MA, Le Foll B.

Drug Alcohol Depend. 2016 Apr 1;161:298-306. doi: 10.1016/j.drugalcdep.2016.02.020. Epub 2016 Feb 23.

10.

Marijuana use patterns and sleep among community-based young adults.

Conroy DA, Kurth ME, Strong DR, Brower KJ, Stein MD.

J Addict Dis. 2016;35(2):135-43. doi: 10.1080/10550887.2015.1132986. Epub 2016 Jan 4.

11.

Weighing the balance: how analgesics used in chronic pain influence sleep?

Bohra MH, Kaushik C, Temple D, Chung SA, Shapiro CM.

Br J Pain. 2014 Aug;8(3):107-18. doi: 10.1177/2049463714525355.

12.

Updates on Nutraceutical Sleep Therapeutics and Investigational Research.

Yurcheshen M, Seehuus M, Pigeon W.

Evid Based Complement Alternat Med. 2015;2015:105256. doi: 10.1155/2015/105256. Epub 2015 Jul 21. Review.

13.

Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.

McPartland JM, Duncan M, Di Marzo V, Pertwee RG.

Br J Pharmacol. 2015 Feb;172(3):737-53. doi: 10.1111/bph.12944. Review.

14.

Potential effects of cannabidiol as a wake-promoting agent.

Murillo-Rodríguez E, Sarro-Ramírez A, Sánchez D, Mijangos-Moreno S, Tejeda-Padrón A, Poot-Aké A, Guzmán K, Pacheco-Pantoja E, Arias-Carrión O.

Curr Neuropharmacol. 2014 May;12(3):269-72. doi: 10.2174/1570159X11666131204235805.

15.

Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome.

Farabi SS, Prasad B, Quinn L, Carley DW.

J Clin Sleep Med. 2014 Jan 15;10(1):49-56. doi: 10.5664/jcsm.3358.

16.

Cannabidiol in humans-the quest for therapeutic targets.

Zhornitsky S, Potvin S.

Pharmaceuticals (Basel). 2012 May 21;5(5):529-52. doi: 10.3390/ph5050529.

17.

Does Cannabidiol Protect Against Adverse Psychological Effects of THC?

Niesink RJ, van Laar MW.

Front Psychiatry. 2013 Oct 16;4:130. doi: 10.3389/fpsyt.2013.00130. Review.

18.

Cannabis, a complex plant: different compounds and different effects on individuals.

Atakan Z.

Ther Adv Psychopharmacol. 2012 Dec;2(6):241-54. doi: 10.1177/2045125312457586.

19.

Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers.

Gorelick DA, Goodwin RS, Schwilke E, Schroeder JR, Schwope DM, Kelly DL, Ortemann-Renon C, Bonnet D, Huestis MA.

Am J Addict. 2013 Sep-Oct;22(5):510-4. doi: 10.1111/j.1521-0391.2013.12003.x.

20.

A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats.

Goonawardena AV, Plano A, Robinson L, Platt B, Hampson RE, Riedel G.

Sleep Disord. 2011;2011:178469. doi: 10.1155/2011/178469. Epub 2012 Jan 4.

Supplemental Content

Support Center